What Is Meldonium? Maria Sharapova Tested Positive for Performance-Enhancing Drug

What Is Meldonium? Maria Sharapova Tested Positive for Performance-Enhancing Drug
Source: AP
Source: AP

Professional tennis player and highest-paid female athlete Maria Sharapova announced in a press conference Monday that she had failed a drug test at the Australian Open, having tested positive for meldonium. The drug — developed in Latvia and intended to treat ischemia, or lack of blood flow — has also been used by some athletes to enhance performance.

Meldonium, also known as Mildronate, was added to the World Anti-Doping Agency monitoring program in 2015 through "evidence of its use by athletes with the intention of enhancing performance." Studies have shown the drug's ability to enhance athletic performance by improving energy metabolism and, in consequence, medical experts have suggested it be added to the list of banned doping agents. The agency dubbed meldonium a prohibited substance effective in January, the Guardian reported.

Read more: Tennis Star Maria Sharapova Admits to Failed Drug Test Amid Rumors She's Retiring

"Of interest to athletes is the finding that it consistently and significantly improves exercise tolerance," Roidvisor's Darius Postovski wrote in a piece about performance-enhancing drugs that are somehow still legal. "Some pharmaceutical companies have recently marketed it explicitly as a performance-enhancing drug. It's also used as a 'smart drug' by nonathletes. Athletes have been using it for over five years."

Sharapova will be temporarily banned from the International Tennis Federation on the anti-doping offense, but it's unclear for how long. Ethiopian-born, Swedish world champion runner Abeba Aregawi is temporarily banned from competing as well after recently testing positive for the same drug.

Correction: March 8, 2016
A previous version of this story stated meldonium "is not explicitly prohibited" by the World Anti-Doping Agency. After placing the drug on its watch list, WADA designated meldonium a banned substance effective in January 2016.

How likely are you to make Mic your go-to news source?

Jessica Eggert

Jessica is a staff writer at Mic, covering breaking news. She is based in New York and can be reached at jessica@mic.com.

MORE FROM

Conservative columnist Bret Stephens joins MSNBC

Stephens will remain a columnist at The New York Times.

Department of Homeland Security announces new airline security rules

The new measures could help end the electronics ban.

Democrats on Neil Gorsuch's first Supreme Court term: "We've got another Scalia"

Some say Gorsuch's even-handed performance during his confirmation hearings "might be more an act than it was a real persona."

Fox News just hired US Rep. Jason Chaffetz as a correspondent

Chaffetz is headed to Fox.

Here are the key rulings from the Supreme Court's busy June term

The court's term ended with rulings on immigration, the First Amendment, LGBTQ rights and more.

These 3 Republican governors could pose the biggest threat to the Senate health care bill

Why some Republican governors oppose their own party's health care bill

Conservative columnist Bret Stephens joins MSNBC

Stephens will remain a columnist at The New York Times.

Department of Homeland Security announces new airline security rules

The new measures could help end the electronics ban.

Democrats on Neil Gorsuch's first Supreme Court term: "We've got another Scalia"

Some say Gorsuch's even-handed performance during his confirmation hearings "might be more an act than it was a real persona."

Fox News just hired US Rep. Jason Chaffetz as a correspondent

Chaffetz is headed to Fox.

Here are the key rulings from the Supreme Court's busy June term

The court's term ended with rulings on immigration, the First Amendment, LGBTQ rights and more.

These 3 Republican governors could pose the biggest threat to the Senate health care bill

Why some Republican governors oppose their own party's health care bill